Cargando…

A 4-miRNA signature predicts the therapeutic outcome of glioblastoma

Multimodal therapy of glioblastoma (GBM) reveals inter-individual variability in terms of treatment outcome. Here, we examined whether a miRNA signature can be defined for the a priori identification of patients with particularly poor prognosis. FFPE sections from 36 GBM patients along with overall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niyazi, Maximilian, Pitea, Adriana, Mittelbronn, Michel, Steinbach, Joachim, Sticht, Carsten, Zehentmayr, Franz, Piehlmaier, Daniel, Zitzelsberger, Horst, Ganswindt, Ute, Rödel, Claus, Lauber, Kirsten, Belka, Claus, Unger, Kristian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216759/ https://www.ncbi.nlm.nih.gov/pubmed/27302927 http://dx.doi.org/10.18632/oncotarget.9945

Ejemplares similares

Improved risk stratification in younger IDH wild-type glioblastoma patients by combining a 4-miRNA signature with MGMT promoter methylation status
por: Unger, Kristian, et al.
Publicado: (2020)

Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients
por: Summerer, Isolde, et al.
Publicado: (2013)

Erratum: Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients
por: Summerer, Isolde, et al.
Publicado: (2015)

MiRNA expression patterns predict survival in glioblastoma
por: Niyazi, Maximilian, et al.
Publicado: (2011)

MicroRNA expression profiles in human cancer cells after ionizing radiation
por: Niemoeller, Olivier M, et al.
Publicado: (2011)

Bevacizumab and radiotherapy for the treatment of glioblastoma: brothers in arms or unholy alliance?
por: Niyazi, Maximilian, et al.
Publicado: (2015)

Systematic in vitro analysis of therapy resistance in glioblastoma cell lines by integration of clonogenic survival data with multi-level molecular data
por: Schnöller, Leon Emanuel, et al.
Publicado: (2023)

Choline PET based dose-painting in prostate cancer - Modelling of dose effects
por: Niyazi, Maximilian, et al.
Publicado: (2010)

Hippocampal EUD in primarily irradiated glioblastoma patients
por: Bodensohn, Raphael, et al.
Publicado: (2014)

A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy‐treated head and neck squamous cell carcinoma (HNSCC)
por: Wintergerst, Ludmila, et al.
Publicado: (2018)

DNA-methylation and genomic copy number in primary tumors and corresponding lymph node metastases in prostate cancer from patients with low and high Gleason score
por: Unger, Kristian, et al.
Publicado: (2023)

Inhibition of HSP90 as a Strategy to Radiosensitize Glioblastoma: Targeting the DNA Damage Response and Beyond
por: Orth, Michael, et al.
Publicado: (2021)

Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cells
por: Summerer, Isolde, et al.
Publicado: (2015)

Validation of the prognostic Heidelberg re-irradiation score in an independent mono-institutional patient cohort
por: Niyazi, Maximilian, et al.
Publicado: (2014)

Recurrence pattern analysis after re-irradiation with bevacizumab in recurrent malignant glioma patients
por: Niyazi, Maximilian, et al.
Publicado: (2014)

Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy
por: Schnöller, Leon Emanuel, et al.
Publicado: (2022)

Automated biological target volume delineation for radiotherapy treatment planning using FDG-PET/CT
por: Niyazi, Maximilian, et al.
Publicado: (2013)

Analysis of equivalent uniform dose (EUD) and conventional radiation treatment parameters after primary and re-irradiation of malignant glioma
por: Niyazi, Maximilian, et al.
Publicado: (2013)

Current status and recent advances in reirradiation of glioblastoma
por: Minniti, Giuseppe, et al.
Publicado: (2021)

Surgery vs. radiotherapy in localized prostate cancer. Which is best?
por: Welz, Stefan, et al.
Publicado: (2008)

Early senescence and production of senescence-associated cytokines are major determinants of radioresistance in head-and-neck squamous cell carcinoma
por: Schoetz, Ulrike, et al.
Publicado: (2021)

Radiotherapy and "new" drugs-new side effects?
por: Niyazi, Maximilian, et al.
Publicado: (2011)

Feasibility study on image guided patient positioning for stereotactic body radiation therapy of liver malignancies guided by liver motion
por: Heinz, Christian, et al.
Publicado: (2016)

Recurrence pattern analysis after [(68)Ga]-DOTATATE-PET/CT -planned radiotherapy of high-grade meningiomas
por: Zollner, Barbara, et al.
Publicado: (2018)

Single-center versus multi-center data sets for molecular prognostic modeling: a simulation study
por: Samaga, Daniel, et al.
Publicado: (2020)

Isobologram analysis of triple therapies
por: Niyazi, Maximilian, et al.
Publicado: (2006)

Counting colonies of clonogenic assays by using densitometric software
por: Niyazi, Maximilian, et al.
Publicado: (2007)

Integration of p16/HPV DNA Status with a 24-miRNA-Defined Molecular Phenotype Improves Clinically Relevant Stratification of Head and Neck Cancer Patients
por: Hess, Julia, et al.
Publicado: (2022)

Definitive chemoradiotherapy in patients with squamous cell cancers of the head and neck - results from an unselected cohort of the clinical cooperation group “Personalized Radiotherapy in Head and Neck Cancer”
por: Schüttrumpf, Lars, et al.
Publicado: (2020)

Transcriptomic analyses of the radiation response in head and neck squamous cell carcinoma subclones with different radiation sensitivity: time-course gene expression profiles and gene association networks
por: Michna, Agata, et al.
Publicado: (2016)

Intra-fraction motion of the prostate is not increased by patient couch shifts
por: Ballhausen, Hendrik, et al.
Publicado: (2016)

Stereoscopic X-ray imaging, cone beam CT, and couch positioning in stereotactic radiotherapy of intracranial tumors: preliminary results from a cross-modality pilot installation
por: Zollner, Barbara, et al.
Publicado: (2016)

Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck – clinical results from the cohort of the clinical cooperation group “Personalized Radiotherapy in Head and Neck Cancer”
por: Maihoefer, Cornelius, et al.
Publicado: (2018)

First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments
por: Combs, Stephanie E., et al.
Publicado: (2020)

Treatment strategies for oesophageal cancer - time-trends and long term outcome data from a large tertiary referral centre
por: Wolf, Maria C, et al.
Publicado: (2012)

Contrast-enhanced, conebeam CT-based, fractionated radiotherapy and follow-up monitoring of orthotopic mouse glioblastoma: a proof-of-concept study
por: Stegen, Benjamin, et al.
Publicado: (2020)

A Novel Subgroup of UCHL1-Related Cancers Is Associated with Genomic Instability and Sensitivity to DNA-Damaging Treatment
por: Burkart, Sebastian, et al.
Publicado: (2023)

High Expression of EpCAM and Sox2 is a Positive Prognosticator of Clinical Outcome for Head and Neck Carcinoma
por: Baumeister, Philipp, et al.
Publicado: (2018)

On the analysis of clonogenic survival data: Statistical alternatives to the linear-quadratic model
por: Unkel, Steffen, et al.
Publicado: (2016)

Post-processing sets of tilted CT volumes as a method for metal artifact reduction
por: Ballhausen, Hendrik, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1dveorld1sm7p6jt562drotbj1